Creative Medical Technology Holdings, Inc. Finance Lease, Liability, to be Paid, Year One
Creative Medical Technology Holdings, Inc. (CELZ) had Finance Lease, Liability, to be Paid, Year One of $92.08 thousand as of 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes › Commitment and Contingencies
us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2023-03-31
- 2022-12-31: Finance Lease, Liability, to be Paid, Year One $92.08K.
- 2021-12-31: Finance Lease, Liability, to be Paid, Year One $60.39K.
- 2020-12-31: Finance Lease, Liability, to be Paid, Year One $93.33K.
| Period end | Finance Lease, Liability, to be Paid, Year One |
|---|---|
| 2022-12-31 | $92.08K 10-K · filed 2023-03-31 |
| 2021-12-31 | $60.39K 10-K · filed 2022-03-30 |
| 2020-12-31 | $93.33K 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |